Neuromuscular transmission in thyrotoxicosis

Area of Science:

• Neurology
• Endocrinology
• Clinical Electrophysiology

Background:

• Thyrotoxicosis and myasthenia gravis show a notable association, with differing incidence rates.
• The underlying mechanisms may involve thyroid hormone effects on the neuromuscular junction or a shared etiology.
• Clinical fatigability in thyrotoxic myopathy might be exacerbated by subclinical myasthenia.

Purpose of the Study:

• To investigate electromyographic signs of latent myasthenia in hyperthyroid patients with chronic myopathy.
• To explore the relationship between hyperthyroidism, myopathy, and neuromuscular transmission abnormalities.

Main Methods:

• Electromyography with repeated nerve stimulation was performed on 48 hyperthyroid patients with chronic myopathy.
• Assessment focused on identifying abnormal neuromuscular transmission and facilitation patterns.

Main Results:

• Eight patients (16.7%) exhibited abnormal neuromuscular transmission, characteristic of myasthenia gravis.
• One of these eight later developed overt ocular myasthenia.
• Three additional patients displayed abnormal facilitation, similar to the Eaton-Lambert syndrome.

Conclusions:

• A significant proportion of hyperthyroid patients with myopathy show subclinical neuromuscular transmission defects.
• These findings support a genuine association between thyrotoxicosis and myasthenia gravis.
• Electromyography is valuable in detecting latent myasthenia in this patient population.